Project Grant W81XWH2210297
Award Date
9/1/22
Completion Date
8/31/25
Dollars Obligated
$499K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Denmark
Similar Awards
This federal Project Grant award, worth $2,966,875.00, was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a prospective clinical trial to investigate the optimal timing of surgical decompression for patients with acute spinal cord injuries. The grant recipient, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, will conduct the research at its facility in Torrance, California over a...
The U.S. Department of the Army Medical Command awarded a $494,774 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Aarhus Universitet, a Danish educational institution, to develop nonmotor biomarkers to diagnose Parkinson's disease subtypes early on. The award, which runs from December 15, 2024 to December 14, 2026, will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
This Project Grant award of $2,056,250.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports research by The Trustees of Columbia University in the City of New York, Health Sciences Division, to target cervical epidural spinal cord stimulation for functional recovery. The project will run from September 1, 2024 to August 31, 2027. This award is part of the DHA's strategy to transform healthcare for military service members,...
The Department of the Army Medical Command awarded a $539,979 project grant to Imperial College London under the Military Medical Research and Development program. The grant will fund research from August 2021 to August 2024 to develop a monoclonal antibody targeting CXCL13 to promote axonal plasticity, regeneration, and functional recovery after spinal cord injury. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $506,232.00 to Imperial College of Science, Technology and Medicine (doing business as Imperial College London) to investigate the repair ability and mechanisms of combinatorial pharmacological and biomaterial-based interventions after experimental spinal cord injury. The award, which begins on Sep 15, 2023 and is scheduled to be completed by Sep 14, 2026,...
The University of British Columbia received a $1.7 million project grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award will support research into noninvasive spinal cord stimulation for recovery of autonomic function after spinal cord injury. Specifically, the university researchers will work to move promising mechanistic findings into clinical practice by investigating medical...
The Department of the Army Medical Command awarded a $711,403 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a project titled "A Noninvasive Neurotrophic Factor Treatment to Repair the Injured Spinal Cord" with a period of performance from October 1, 2024 to September 30, 2027. This project grant supports advanced biomedical research focused...
This federal Project Grant award of $325,142, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, which has a performance period from September 1, 2025 to August 31, 2028, is being provided to Onward Medical Inc., a for-profit organization located in Boston, MA. The goal of this...
This Project Grant award of $568,114.00 from the Defense Health Agency was made to Ecole Polytechnique Fédérale De Lausanne (EPFL), a university in Lausanne, Switzerland, to conduct research and development related to baroprosthesis to reduce secondary damage of traumatic spinal cord injury. The award was made under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members and the public. The research...
The Defense Health Agency awarded a $1,332,764 Project Grant to Neurocreis, Inc. in College Station, TX under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the "Therapeutic Development of NC101 for Promoting Neurological Recovery After Chronic SCI", with a performance period from July 1, 2025 to June 30, 2028. The funding will enable Neurocreis to conduct advanced biomedical research aimed at transforming healthcare for military service...